SCHEMBL6017469

SCHEMBL6017469

CS(=O)(=O)N(CC(=O)N1CCC(Oc2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)cc4)c3c2)CC1)S(C)(=O)=O

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 13/20 0.61
ERBB2 P04626 12/20 0.50
FAAH O00519 1/20 0.48
ERBB4 Q15303 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5568052 0.92 EGFR (0.63) EGFRERBB2FAAHERBB4
SCHEMBL5568894 0.85 EGFR (0.64) EGFRERBB2ERBB4
SCHEMBL5564412 0.85 EGFR (0.76) EGFRERBB2ERBB4
SCHEMBL5564631 0.83 EGFR (0.57) EGFRERBB2
SCHEMBL5567844 0.79 ERBB2 (0.58) EGFRERBB2
Hydrochloric Acid SCHEMBL5564704 0.78 ERBB2 (0.57) EGFRERBB2
SCHEMBL5564452 0.78 EGFR (0.61) EGFRERBB2ERBB4
SCHEMBL5565179 0.78 EGFR (0.56) EGFRERBB2ERBB4
SCHEMBL6017397 0.76 EGFR (0.60) EGFRERBB2ERBB4
SCHEMBL3434522 0.76 EGFR (1.00) EGFRERBB2ERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664028-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS AstraZeneca AB (SE) 2006-06-07 EP claimed
WO-2005026151-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2005-03-24 WO claimed